What is the total value of India's pharmaceutical export to China?

India exported pharmaceuticals worth $767.5M to China across 4,376 verified shipments.

Which companies in China import pharmaceuticals from India?

1. AUROBINDO PHARMA LTD — $53.7M. 2. BIOLOGICAL E. LIMITED — $41.1M. 3. TROIKAA PHARMACEUTICALS LIMITED — $23.2M. 231 buyers total.

What pharmaceutical products does India export most to China?

1. Sodium ($300.5M, 39.2%); 2. Heparin ($203.0M, 26.4%); 3. Potassium ($98.5M, 12.8%); 4. Insulin ($41.5M, 5.4%); 5. Protein ($40.5M, 5.3%)

Why does China import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $767.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply China?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to China pharmaceutical trade?

$175.4K per consignment across 4,376 shipments.

How many Indian pharmaceutical companies export to China?

416 Indian companies. Largest: YINO PHARMA LIMITED with $48.8M.

How can I find verified Indian pharmaceutical suppliers for China?

TransData Nexus covers 416 active exporters with shipment history and trade values at transdatanexus.com.

China to India Pharmaceutical Import (2026) — $767.5M, 416 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to China?

1. YINO PHARMA LIMITED — $48.8M. 2. SHANDONG NEW TIME PHARMACEUTICAL CO LTD — $31.0M. 3. YANTAI DONGCHENG BIOCHEMICALS CO.,LTD — $28.0M. Total: 416 suppliers.

China to India Pharmaceutical Import (2026) — $767.5M, 416 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — China to India

#	Formulation	Value	Share
1	Sodium	$300.5M	39.2%
2	Heparin	$203.0M	26.4%
3	Potassium	$98.5M	12.8%
4	Insulin	$41.5M	5.4%
5	Protein	$40.5M	5.3%
6	Vaccine	$20.7M	2.7%
7	Piperacillin	$19.1M	2.5%
8	Amoxicillin	$8.3M	1.1%
9	Semaglutide	$3.9M	0.5%
10	Enoxaparin	$3.2M	0.4%
11	Ivermectin	$3.0M	0.4%
12	Tetracycline	$2.5M	0.3%
13	Vitamin	$2.4M	0.3%
14	Chondroitin	$2.1M	0.3%
15	Antitoxin	$1.9M	0.3%

India imports 20+ pharmaceutical formulations from China with a combined trade value of $767.5M. Key products include Sodium ($300.5M), Heparin ($203.0M), Potassium ($98.5M), Insulin ($41.5M), Protein ($40.5M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 4,376 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — China to India Trade Routes

1Sodium$300.5M

2Heparin$203.0M

3Potassium$98.5M

4Insulin$41.5M

5Protein$40.5M

Top China Suppliers to India

1Yino Pharma Limited

$48.8M

2Shandong New Time Pharmaceutical Co Ltd

$31.0M

3Yantai Dongcheng Biochemicals Co.,ltd

$28.0M

4Yino Pharma Ltd

$12.1M

5Hubei Enoray Biopharmaceutical Co., Ltd.

$8.1M

Trade Statistics

Total Value$767.5M

Shipments4,376

Indian Exporters416

China Buyers231

Avg Shipment$175K

Products155

Other Import Origins

United States$2.7B Germany$929.2M Italy$471.9M France

Last updated: March 28, 2026

India–China Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between China and India has experienced significant growth over the past decade. In 2022, India's pharmaceutical imports from China were valued at approximately $767.5 million USD, encompassing 4,376 shipments from 416 Chinese suppliers to 231 Indian buyers. This surge reflects China's expanding role as a key supplier of finished pharmaceutical formulations to India. The trade has been characterized by a diverse range of products, with sodium, heparin, and potassium leading the import categories. Notably, the average shipment value stands at $175,000 USD, indicating a mix of bulk and specialized pharmaceutical products.

2China's Role in India's Pharma Imports

China has become a pivotal source of pharmaceutical imports for India, supplying a wide array of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The dominance of sodium, heparin, and potassium in the import list underscores China's strength in producing essential and high-demand pharmaceutical ingredients. This trend highlights China's capacity to meet India's growing pharmaceutical needs, particularly in critical therapeutic areas.

3Recent Developments

China Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For Chinese pharmaceutical companies aiming to export finished formulations to India, obtaining CDSCO registration is mandatory. The process involves several key steps:

1. Application Submission: Companies must submit an online application through the CDSCO portal, providing detailed information about the product and manufacturing site.

2. Documentary Requirements: Essential documents include a valid manufacturing license, Certificate of Pharmaceutical Product (CPP), Free Sale Certificate, and a site master file detailing manufacturing processes.

3. Clinical Trial Data: Depending on the product, clinical trial data may be required. However, CDSCO may grant waivers for certain products based on existing approvals in other jurisdictions.

4. Review and Approval: CDSCO evaluates the application to ensure compliance with Indian standards. This may involve inspections and consultations with subject-matter experts.

The entire registration process can take several months, depending on the complexity of the product and the completeness of the application.

2GMP & Manufacturing Standards

India mandates that all imported pharmaceutical products adhere to stringent GMP standards to ensure quality and safety. Chinese manufacturing sites must comply with these standards, which are aligned with international guidelines. CDSCO conducts inspections to verify compliance, and products must be WHO prequalified or meet equivalent standards. Non-compliance can result in rejection of the import application and potential bans on future shipments.

3Import Documentation

Importing pharmaceutical products into India requires comprehensive documentation:

1. Import License (Form 10): Issued by CDSCO, this license authorizes the import of specific pharmaceutical products.

2. Registration Certificate: Confirms that the product has been approved for sale in India.

3. No Objection Certificate (NOC): Required for certain products, indicating no objection from the manufacturer or other regulatory bodies.

4. Test License: Allows for testing of the imported product to ensure it meets Indian standards.

5. Customs Procedures: Compliance with Indian customs regulations is essential, including proper labeling, packaging, and payment of applicable duties and taxes.

TransData Nexus Research · China regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to China identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 4,376 verified shipments from 416 Indian exporters to 231 China buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

416 Exporters

231 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

China to India Pharmaceutical Import

Top Pharmaceutical Formulations — China to India

Top Pharmaceutical Products — China to India Trade Routes

Top China Suppliers to India

Trade Statistics

Other Import Origins

India–China Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2China's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from China

Product Routes

Full Dataset Access

China Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to China

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and China

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to China Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — China for Indian Pharma

1India's Import Dependency

2China Companies in India

3Outlook & Self-Reliance

FAQ — India to China Pharmaceutical Trade